FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA's sign-off on the medication comes as the agency says it is prioritizing supporting the development of non-opioid ...
Alberta demands Ottawa either repeal 'soft' drug prosecutions or let province take over
Drug crimes in most provinces, including Alberta, are prosecuted by federal Crown prosecutors from the Public Prosecution ...
Fox News9d
FDA approves opioid-free pain medication with 'no sign of addiction'
The new drug is intended for treatment of moderate ... also applauded the approval of suzetrigine. "It has no sign of addiction, which makes it a hugely important new tool as we fight the opioid ...
US FDA identifies cybersecurity risks in certain patient monitors
The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with ...
AOL9d
FDA approves opioid-free pain medication with 'no sign of addiction'
"This drug is a big step forward and has been well ... company to ensure that it is covered," she advised. Click Here To Sign Up For Our Health Newsletter The medication is expected to fall ...
Yahoo News9d
FDA approves opioid-free pain medication with 'no sign of addiction'
A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex, is ...
CNN on MSN14d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
Telangana: TGCHE, Bulk Drug Manufacturers Association of India sign MoU
Tie-up aims at nurturing skilled workforce for pharma industry, aligning educational training with industry needs, ensuring ...
Novo Nordisk defends next-gen obesity drug CagriSema, details new trial
Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...
CNN14d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...